Alexa
  • Directory of Taiwan

Jury deliberates for 5th day at Martin Shkreli's fraud trial

Former pharmaceutical company CEO Martin Shkreli, left, walks out of federal court with his attorney Benjamin Brafman, Thursday, Aug. 3, 2017, in New ...
Former pharmaceutical company CEO Martin Shkreli, right, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New Yor...
Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team Thursday, Aug. 3, 2017, in New Yor...
Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New Yo...
Former pharmaceutical company CEO Martin Shkreli stands at an intersection after leaving federal court with his legal team, Thursday, Aug. 3, 2017, in...
Former pharmaceutical company CEO Martin Shkreli, second from left, walks out of federal court with his legal team Thursday, Aug. 3, 2017, in New York...
Martin Shkreli arrives at federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal secu...

Former pharmaceutical company CEO Martin Shkreli, left, walks out of federal court with his attorney Benjamin Brafman, Thursday, Aug. 3, 2017, in New ...

Former pharmaceutical company CEO Martin Shkreli, right, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New Yor...

Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team Thursday, Aug. 3, 2017, in New Yor...

Former pharmaceutical company CEO Martin Shkreli, center, walks out of federal court with members of his legal team, Thursday, Aug. 3, 2017, in New Yo...

Former pharmaceutical company CEO Martin Shkreli stands at an intersection after leaving federal court with his legal team, Thursday, Aug. 3, 2017, in...

Former pharmaceutical company CEO Martin Shkreli, second from left, walks out of federal court with his legal team Thursday, Aug. 3, 2017, in New York...

Martin Shkreli arrives at federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal secu...

NEW YORK (AP) — Jurors are deliberating for a fifth day at the federal securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL'-ee).

They got the case Monday and were still grappling with it Friday in New York City.

Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

The former biotech CEO, nicknamed "Pharma Bro," is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

If convicted of the most serious charges, he could face up to 20 years in prison but likely would receive far less time under sentencing guidelines.


Updated : 2021-08-03 08:16 GMT+08:00